Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Cis Atracurium Besylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 33,359Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of December 24, 2025
    Enforcement Report - Week of December 24, 2025

    24 Dec 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-24-2025-58363.pdf

    FDA
    24 Dec 2025
    Share Share
    Health Canada Issues Recalls of Cisatracurium Besylate Inj
    Health Canada Issues Recalls of Cisatracurium Besylate Inj

    18 Feb 2025

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/cisatracurium-besylate-injection-usp-multidose-level-degradation-product-benzaldehyde

    HEALTH CANADA
    18 Feb 2025
    Share Share
    Hainan Poly`s Generics Cisatracurium Besylate Receives Approval in US
    Hainan Poly`s Generics Cisatracurium Besylate Receives Approval in US

    27 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216539

    FDA
    27 Aug 2024
    Share Share
    Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.
    Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.

    08 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216538

    FDA
    08 Mar 2024
    Share Share
    Caplin's Generic Cisatracurium Besylate Receives Approval in the U.S.
    Caplin's Generic Cisatracurium Besylate Receives Approval in the U.S.

    09 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217725

    FDA
    09 Jun 2023
    Share Share
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients

    30 Jan 2023

    // PRESS RELEASE

    http://cfpharma.hu/development-of-manufacturing-technology-for-three-pharmaceutical-ingredients/

    PRESS RELEASE
    30 Jan 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.